Premature labour precipitated by highly active antiretroviral therapy: an adverse reaction in a newly diagnosed HIV-positive patient.

A pregnant woman was diagnosed with HIV infection at 29 weeks' gestation. Antiretroviral therapy (ART) of lopinavir-ritonavir and zidovudine-lamivudine was initiated. Ten days later, a hypersensitivity reaction occurred, followed by preterm delivery of the infant 3 days later at 30 weeks' gestation. Hypersensitivity reactions to ART should prompt urgent consideration of a change in ART to avoid the potential for adverse pregnancy outcomes.

[1]  Lois E. H. Smith,et al.  High or Low Oxygen Saturation and Severe Retinopathy of Prematurity: A Meta-analysis , 2010, Pediatrics.

[2]  I. Baron,et al.  Extremely Preterm Birth Outcome: A Review of Four Decades of Cognitive Research , 2010, Neuropsychology Review.

[3]  E. Livingston,et al.  Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy. , 2010, The Journal of infectious diseases.

[4]  M. Hellard,et al.  Antenatal screening practice for infectious diseases by general practitioners in Australia , 2009, The Australian & New Zealand journal of obstetrics & gynaecology.

[5]  D. Zaknun,et al.  Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV‐1‐infected women , 2008, HIV medicine.

[6]  L. Wolf,et al.  Frequent detection of acute HIV infection in pregnant women , 2007, AIDS.

[7]  G. Guaraldi,et al.  Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women. , 2007, The Journal of infectious diseases.

[8]  C. Schmid,et al.  Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis , 2007, AIDS.

[9]  I. Song,et al.  [A case of severe skin eruption caused by lamivudine in a patient with chronic hepatitis B]. , 2006, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[10]  D. Calista Maculo-papular rash induced by lopinavir/ritonavir. , 2005, European journal of dermatology : EJD.

[11]  M. Newell,et al.  Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe , 2004, AIDS.

[12]  Swiss Mother Combination antiretroviral therapy and duration of pregnancy , 2000, AIDS.

[13]  J. Kennedy Lung function outcome in children of premature birth , 1999, Journal of paediatrics and child health.

[14]  R. Murri,et al.  Fatal toxic epidermolysis induced by zidovudine. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  M. Wassef,et al.  Hypersensitivity of zidovudine: report of a case of anaphylaxis and review of the literature. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  R. Stern,et al.  Cutaneous disease and drug reactions in HIV infection. , 1993, The New England journal of medicine.

[17]  R. Lin,et al.  Zidovudine-induced leukocytoclastic vasculitis. , 1992, Archives of internal medicine.

[18]  M. Grieco,et al.  Urticarial reaction to zidovudine , 1990, The Lancet.